Vistagen sued by pro se plaintiffs over alleged misleading clinical trial disclosures

Vistagen Therapeutics, Inc.

John Cesario and David Preka filed lawsuit on Feb 13, 2025 (Case No. 4:25-cv-01510) in Northern District of California.
Complaint alleges violations of Sections 10(b), Rule 10b-5, Sections 11 and 17(a) over public disclosures on clinical trials.
Plaintiffs seek compensatory, punitive damages, fees, and costs.
Vistagen believes allegations are wholly without merit and intends to defend vigorously.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.